COMPUGROUP MEDICAL SE & CO. KGAA CompuGroup Medical agrees to acquire INSIGHT Health

Directive transparence : information réglementée

25/03/2022 15:52

DGAP-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Takeover
CompuGroup Medical agrees to acquire INSIGHT Health

25-March-2022 / 15:52 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Koblenz, March 25, 2022 - Today, CompuGroup Medical Deutschland AG, a 100 % subsidiary of CompuGroup Medical SE & Co. KGaA (the "Company"), has entered into an agreement with RLPR AG and INSIGHT Health Holding GmbH to acquire all participation in the INSIGHT Health Group.

The INSIGHT Health Group, consisting of INSIGHT Health GmbH & Co. KG, its general partner INSIGHT Health Management GmbH and Gesellschaft für statistische Gesundheitsforschung mbH, all based in Waldems, Germany, is active in the field of so-called "market intelligence analysis" of health data. With the transaction, the Company is strengthening its offering in the area of market intelligence analysis of healthcare data. In the financial year 2021, the INSIGHT Health Group generated revenues of approximately EUR 36 million.

The purchase price for the 100% participation in the INSIGHT Health Group is between EUR 61 million and EUR 63 million, depending on future corporate developments. These amounts reflect the adjustments for net debt, working capital and trade tax on the capital gain payable by the target companies.

The closing of the transaction is subject to merger control clearance by the competent authorities. The closing is expected in the course of the coming months.

25-March-2022 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language: English
Company: CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Phone: +49 (0)261 8000 7030
Fax: +49 (0)261 8000 3200
E-mail: investor@cgm.com
Internet: www.cgm.com
ISIN: DE000A288904
WKN: A28890
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1312467

End of Announcement DGAP News Service

1312467  25-March-2022 CET/CEST